Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 24 02:44PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-3.54 Insider Own27.60% Shs Outstand6.77M Perf Week-9.35%
Market Cap8.53M Forward P/E- EPS next Y-2.10 Insider Trans18.21% Shs Float4.90M Perf Month-10.00%
Income-14.42M PEG- EPS next Q-0.51 Inst Own11.39% Short Float0.83% Perf Quarter-21.25%
Sales0.15M P/S56.87 EPS this Y37.72% Inst Trans2.02% Short Ratio0.06 Perf Half Y-33.33%
Book/sh2.45 P/B0.51 EPS next Y1.17% ROA-99.26% Short Interest0.04M Perf Year-68.18%
Cash/sh1.64 P/C0.77 EPS next 5Y- ROE-105.30% 52W Range1.20 - 7.13 Perf YTD-27.58%
Dividend Est.- P/FCF- EPS past 5Y77.95% ROI-124.83% 52W High-82.33% Beta61.66
Dividend TTM- Quick Ratio10.71 Sales past 5Y23.65% Gross Margin-53.47% 52W Low5.00% ATR (14)0.11
Dividend Ex-Date- Current Ratio10.71 EPS Y/Y TTM30.87% Oper. Margin-10439.49% RSI (14)41.28 Volatility9.85% 7.83%
Employees11 Debt/Eq0.01 Sales Y/Y TTM21.70% Profit Margin-9887.16% Recom1.00 Target Price10.50
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q49.37% Payout- Rel Volume0.11 Prev Close1.34
Sales Surprise- EPS Surprise- Sales Q/Q421.62% Earnings- Avg Volume665.81K Price1.26
SMA20-6.49% SMA50-7.33% SMA200-33.52% Trades Volume57,297 Change-5.97%
Apr-16-24 07:45AM
Apr-14-24 03:00PM
Apr-08-24 07:45AM
Apr-03-24 04:38PM
Apr-02-24 09:53AM
07:45AM Loading…
Apr-01-24 07:45AM
Mar-11-24 04:15PM
Feb-14-24 09:15AM
Feb-06-24 08:05AM
Feb-05-24 07:30AM
Feb-01-24 07:30AM
Dec-12-23 09:15AM
Dec-03-23 01:11PM
Oct-09-23 12:10PM
Oct-02-23 09:14AM
09:00AM Loading…
Sep-18-23 09:00AM
Sep-12-23 10:30AM
Sep-08-23 08:30AM
Aug-30-23 09:00AM
Aug-08-23 06:05PM
Aug-02-23 09:00AM
Jul-31-23 08:05AM
Jul-26-23 01:01PM
Jul-21-23 07:10AM
Jul-11-23 08:30AM
Jul-07-23 07:00AM
Jun-27-23 08:30AM
Jun-26-23 07:30AM
08:36AM Loading…
Jun-17-23 08:36AM
Jun-16-23 07:00AM
Jun-15-23 07:48AM
Jun-12-23 08:31AM
Jun-01-23 09:15AM
May-31-23 08:30AM
May-15-23 08:31AM
May-12-23 07:15AM
May-08-23 07:00AM
May-04-23 07:00AM
Apr-24-23 08:30AM
Mar-31-23 08:30AM
Mar-28-23 07:01AM
Mar-22-23 09:15AM
Mar-13-23 08:30AM
Mar-09-23 06:30AM
Mar-07-23 06:30AM
Mar-02-23 09:00AM
Feb-10-23 08:45AM
Feb-08-23 09:00AM
Feb-03-23 09:25AM
Jan-26-23 08:30AM
Jan-17-23 09:29AM
Dec-06-22 07:00AM
Dec-05-22 07:00AM
Nov-29-22 11:20AM
Nov-16-22 08:56AM
Nov-10-22 08:00AM
Oct-31-22 08:15AM
Oct-20-22 09:30AM
Oct-14-22 08:00AM
Sep-28-22 07:00AM
Sep-27-22 07:00AM
Sep-07-22 07:00AM
Sep-01-22 09:00AM
Aug-25-22 03:49PM
Aug-24-22 06:30AM
Jun-30-22 07:30AM
Jun-22-22 07:30AM
Jun-13-22 07:00AM
Apr-29-22 08:00AM
Apr-18-22 08:00AM
Apr-04-22 08:00AM
Mar-10-22 08:00AM
Feb-16-22 08:30AM
Feb-07-22 09:00AM
Feb-02-22 08:00AM
Jan-26-22 06:00AM
Jan-11-22 06:00AM
Jan-06-22 06:00AM
Jan-04-22 06:00AM
Dec-22-21 07:28AM
Dec-21-21 04:01PM
Dec-20-21 06:00AM
Dec-02-21 06:00AM
Nov-23-21 04:05PM
BioRestorative Therapies, Inc. engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company's initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process. BioRestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Silva FranciscoVP of Research and DevelopmentApr 09 '24Buy1.256,6008,250155,759Apr 10 05:16 PM
Silva FranciscoVP of Research and DevelopmentApr 08 '24Buy1.161,7081,979149,159Apr 10 05:16 PM
Broadrick Dale10% OwnerFeb 09 '24Buy1.3286,041113,574477,972Feb 12 09:26 AM
Broadrick Dale10% OwnerFeb 08 '24Buy1.3483,626112,059447,045Feb 09 08:00 AM
Broadrick Dale10% OwnerFeb 08 '24Buy1.2573,95992,449391,931Feb 12 09:26 AM
Broadrick Dale10% OwnerFeb 07 '24Buy1.3836,37450,196363,419Feb 09 08:00 AM
Broadrick Dale10% OwnerDec 01 '23Sale1.88250469327,045Dec 05 04:32 PM
Broadrick Dale10% OwnerNov 27 '23Sale1.89278525327,295Dec 01 05:04 PM
Broadrick Dale10% OwnerSep 15 '23Buy1.6610,00016,600327,573Sep 18 09:20 AM
ALSTODT LANCEPresident, CEO, COBSep 15 '23Buy1.702,2003,740189,505Sep 18 09:17 AM
Broadrick Dale10% OwnerSep 14 '23Buy1.5410,00015,400317,573Sep 18 09:20 AM
ALSTODT LANCEPresident, CEO, COBSep 13 '23Buy1.538001,226188,105Sep 13 05:00 PM
Broadrick Dale10% OwnerSep 07 '23Buy1.911,0001,910317,972Sep 14 04:08 PM
Broadrick Dale10% OwnerSep 07 '23Buy1.811,0001,810307,573Sep 14 04:08 PM
ALSTODT LANCEPresident, CEO, COBSep 06 '23Buy1.962,8875,659187,305Sep 06 05:53 PM
Silva FranciscoVP of Research and DevelopmentAug 31 '23Buy2.224,95410,998164,644Aug 31 01:54 PM
Broadrick Dale10% OwnerJul 28 '23Buy2.895001,445306,573Sep 14 04:08 PM
Broadrick Dale10% OwnerJul 27 '23Buy2.801,0002,800306,073Jul 28 11:17 AM
ALSTODT LANCEPresident, CEO, COBJul 25 '23Buy2.444,20010,248184,418Jul 25 05:56 PM